The DOI matches its Crossref record; 421 of the 427 references it cites were found in a registry or an index.
Cost of disorders of the brain in Europe 2010
Open accessAbstract
Background The spectrum of disorders of the brain is large, covering hundreds of disorders that are listed in either the mental or neurological disorder chapters of the established international diagnostic classification systems. These disorders have a high prevalence as well as short- and long-term impairments and disabilities. Therefore they are an emotional, financial and social burden to the patients, their families and their social network. In a 2005 landmark study, we estimated for the first time the annual cost of 12 major groups of disorders of the brain in Europe and gave a conservative estimate of €386 billion for the year 2004. This estimate was limited in scope and conservative due to the lack of sufficiently comprehensive epidemiological and/or economic data on several important diagnostic groups. We are now in a position to substantially improve and revise the 2004 estimates. In the present report we cover 19 major groups of disorders, 7 more than previously, of an increased range of age groups and more cost items. We therefore present much improved cost estimates. Our revised estimates also now include the new EU member states, and hence a population of 514 million people.Aims To estimate the number of persons with defined disorders of the brain in Europe in 2010, the total cost per person related to each disease in terms of direct and indirect costs, and an estimate of the total cost per disorder and country.Methods The best available estimates of the prevalence and cost per person for 19 groups of disorders of the brain (covering well over 100 specific disorders) were identified via a systematic review of the published literature. Together with the twelve disorders included in 2004, the following range of mental and neurologic groups of disorders is covered: addictive disorders, affective disorders, anxiety disorders, brain tumor, childhood and adolescent disorders (developmental disorders), dementia, eating disorders, epilepsy, mental retardation, migraine, multiple sclerosis, neuromuscular disorders, Parkinson's disease, personality disorders, psychotic disorders, sleep disorders, somatoform disorders, stroke, and traumatic brain injury. Epidemiologic panels were charged to complete the literature review for each disorder in order to estimate the 12-month prevalence, and health economic panels were charged to estimate best cost-estimates. A cost model was developed to combine the epidemiologic and economic data and estimate the total cost of each disorder in each of 30 European countries (EU27+Iceland, Norway and Switzerland). The cost model was populated with national statistics from Eurostat to adjust all costs to 2010 values, converting all local currencies to Euro, imputing costs for countries where no data were available, and aggregating country estimates to purchasing power parity adjusted estimates for the total cost of disorders of the brain in Europe 2010.Results The total cost of disorders of the brain was estimated at €798 billion in 2010. Direct costs constitute the majority of costs (37% direct healthcare costs and 23% direct non-medical costs) whereas the remaining 40% were indirect costs associated with patients' production losses. On average, the estimated cost per person with a disorder of the brain in Europe ranged between €285 for headache and €30,000 for neuromuscular disorders. The European per capita cost of disorders of the brain was €1550 on average but varied by country. The cost (in billion €PPP 2010) of the disorders of the brain included in this study was as follows: addiction: €65.7; anxiety disorders: €74.4; brain tumor: €5.2; child/adolescent disorders: €21.3; dementia: €105.2; eating disorders: €0.8; epilepsy: €13.8; headache: €43.5; mental retardation: €43.3; mood disorders: €113.4; multiple sclerosis: €14.6; neuromuscular disorders: €7.7; Parkinson's disease: €13.9; personality disorders: €27.3; psychotic disorders: €93.9; sleep disorders: €35.4; somatoform disorder: €21.2; stroke: €64.1; traumatic brain injury: €33.0. It should be noted that the revised estimate of those disorders included in the previous 2004 report constituted €477 billion, by and large confirming our previous study results after considering the inflation and population increase since 2004. Further, our results were consistent with administrative data on the health care expenditure in Europe, and comparable to previous studies on the cost of specific disorders in Europe. Our estimates were lower than comparable estimates from the US.Discussion This study was based on the best currently available data in Europe and our model enabled extrapolation to countries where no data could be found. Still, the scarcity of data is an important source of uncertainty in our estimates and may imply over- or underestimations in some disorders and countries. Even though this review included many disorders, diagnoses, age groups and cost items that were omitted in 2004, there are still remaining disorders that could not be included due to limitations in the available data. We therefore consider our estimate of the total cost of the disorders of the brain in Europe to be conservative. In terms of the health economic burden outlined in this report, disorders of the brain likely constitute the number one economic challenge for European health care, now and in the future. Data presented in this report should be considered by all stakeholder groups, including policy makers, industry and patient advocacy groups, to reconsider the current science, research and public health agenda and define a coordinated plan of action of various levels to address the associated challenges.Recommendations Political action is required in light of the present high cost of disorders of the brain. Funding of brain research must be increased; care for patients with brain disorders as well as teaching at medical schools and other health related educations must be quantitatively and qualitatively improved, including psychological treatments. The current move of the pharmaceutical industry away from brain related indications must be halted and reversed. Continued research into the cost of the many disorders not included in the present study is warranted. It is essential that not only the EU but also the national governments forcefully support these initiatives.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The economic costs of headaches are substantial, primarily manifesting as indirect and intangible costs. This includes work absences because of headaches (absenteeism), reduced on-the-job performance while experiencing headaches (presenteeism), reduced quality of life, and increased pain outside the workplace [5-7].”
In the citing paper
“Persistent depressive disorder (PDD) is characterized by psychosocial impairment (Angst et al. 2009; Gustavsson et al. 2011; Klein et al. 1988), high comorbidity (Köhler et al. 2019), low rates of spontaneous remission (McCullough et al. 1988) and poorer treatment outcomes compared to episodic depression (Stewart et al. 1989; Thase et al. 1994).”
From Reciprocal Dynamics of Therapeutic Alliance and Depressive Symptoms in Inpatient Cognitive Behavioural Analysis System of Psychotherapy: The Role of Attachment Insecurity. (2025) · cites this paper as Gustavsson et al. 2011
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,656
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183
Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective
Young, T., Peppard, P. E., & Gottlieb, D. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109080 · Cited by 4,244
Estimates of the cancer incidence and mortality in Europe in 2006
Ferlay, J., Autier, P., Boniol, M., Heanue, M., Colombet, M., & Boyle, P. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl498 · Cited by 4,032
Comprehensive Textbook of Psychiatry
Freedman, A. M., & Kaplan, H. I. (1967) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196712000-00052 · Cited by 3,825
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Self-citationOosterhuis, H. (1997) · Cited by 2,397
Estimates of cancer incidence and mortality in Europe in 2008
Ferlay, J., Parkin, D. M., & Steliarova‐Foucher, E. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.014 · Cited by 2,323
Epidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971
Research works printed but not linked: 8
- Atance Martinez, 2004, Costs study in Alzheimer's disease, Rev. Clin. Esp., 204, 64
- Bertelli, 2009, New contributions of psychiatric research in the field of intellectual disabilities, Adv. Psychiatry, 3, 37
- Cavallo, 1997, The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy, Alzheimer Dis. Assoc. Disord., 11, 184
- Gessner, 1993, The cost of epilepsy in Switzerland, Int. J. Health Sci., 4, 121
- Mahdi-Rogers, 2008, Epidemiology and treatment of chronic inflammatory neuropathies in South East England, Eur. J. Neurol., 15
- Salize, 2004, Cost of care for depressive disorders in primary and specialized care in Germany, Psychiatr. Prax., 31, 147
- Wilms, 2004, Illness related costs for spouses of patients suffering from a mental illness: results of a study with repeated measurements, Psychiatr. Prax., 31, 177
- Wittchen, 2010, The timing of depression: an epidemiological perspective, Medicographia, 32, 155-125
Cited by
Sorted by citations
Items 901–1,000 of 1,008
Feng, R., Zhu, Q., Li, Q., Zhai, Y., Wang, J., Qin, C., Liang, D., Zhang, R., Tian, H., Liu, H., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1117726 · Cited by 10
Data-driven scientific research based on public statistics: a bibliometric perspective
Velasco-López, J.-E., Carrasco, R. A., Cobo, M. J., & Fernández‐Avilés, G. (2023) · El Profesional de la Informacion · doi:10.3145/epi.2023.may.14 · Cited by 10
Association between neurological disorders, functioning, and mortality in the elderly
Czira, M. E., Baune, B. T., Roesler, A., Pfadenhauer, K., Trenkwalder, C., & Berger, K. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12220 · Cited by 10
Schwab, M. E., & Buchli, A. D. (2012) · Nature · doi:10.1038/483267a · Cited by 10
Joëls, M., & Mason, C. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.021 · Cited by 10
Preventing brain disorders: a framework for action
Rudenstine, S., & Galea, S. (2015) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-015-1007-4 · Cited by 11
Castellanos, M., Gubern, C., & Kádár, E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802733-2.00012-8 · Cited by 10
Lee, Y., Lin, K., & Chien, T. (2019) · Annals of General Psychiatry · doi:10.1186/s12991-019-0228-4 · Cited by 10
Sitnikova, K., Finch, A. P., Leone, S. S., Bosmans, J. E., van Marwijk, H., van der Horst, H. E., & van der Wouden, J. C. (2020) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2020.110217 · Cited by 11
Automatic EEG processing for the early diagnosis of Traumatic Brain Injury
Albert, B., Zhang, J., Noyvirt, A., Setchi, R., Sjaaheim, H., Velikova, S., & Strisland, F. (2016) · World Automation Congress (WAC) · doi:10.1109/wac.2016.7582957 · Cited by 10
Michel, C., Lerch, S., Büetiger, J. R., Flückiger, R., Cavelti, M., Koenig, J., Kaess, M., & Kindler, J. (2022) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-022-02003-9 · Cited by 12
Wirksamkeit universeller und selektiver Prävention von Depression im Kindes- und Jugendalter
Schulte‐Körne, G., & Schiller, Y. (2012) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000198 · Cited by 10
Consensus Statement on European Brain Research: the need to expand brain research in Europe – 2015
Morris, R., Oertel, W. H., Gäebel, W., Goodwin, G. M., Little, A., Montellano, P., Westphal, M., Nutt, D. J., & Luca, M. D. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13236 · Cited by 10
The potential of gene delivery for the treatment of traumatic brain injury
Dooley, J., Hughes, J. G., Needham, E., Palios, K. A., & Liston, A. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03156-x · Cited by 9
The Interdisciplinary Synergy Between Neurology and Psychiatry: Advancing Brain Health
Accorroni, A., Nencha, U., & Bègue, I. (2025) · Clinical and Translational Neuroscience · doi:10.3390/ctn9010018 · Cited by 9
PET tracer development for imaging α-synucleinopathies
Alam, M. M., Lee, S. H., Wasim, S., & Lee, S. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01538-0 · Cited by 9
Zhang, X., Ji, Y., Yang, Z., Luo, Y., & Li, L. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-23008-6 · Cited by 9
Bulteau, S., Malo, R., Holland, Z., Laurin, A., & Sauvaget, A. (2023) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1644 · Cited by 14
Perdigão, J. M., Teixeira, B. J. B., Baia-da-Silva, D. C., Nascimento, P. C., Lima, R. R., & Rogez, H. L. G. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1149143 · Cited by 9
Hickie, I. B., Iorfino, F., Rohleder, C., Song, Y. J. C., Nichles, A., Zmicerevska, N., Capon, W., Guastella, A. J., Leweke, F. M., Scott, J. L., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-072082 · Cited by 9
Anxiety in post-covid-19 syndrome – prevalence, mechanisms and treatment
Burkauskas, J., Branchi, I., Pallanti, S., & Domschke, K. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.103932 · Cited by 13
García-Estela, A., Angarita‐Osorio, N., Holzhausen, M. C., Mora-Salgueiro, J., Pérez, V., Duarte, E., Faulkner, G., & Colom, F. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.191 · Cited by 13
Schaefer, J. K., Engert, V., Valk, S. L., Singer, T., & Puhlmann, L. M. C. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100781 · Cited by 11
Carota, A., & Calabrese, P. (2014) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000360062 · Cited by 9
The real world cost and health resource utilization associated to manic episodes: The MANACOR study
Hidalgo‐Mazzei, D., Undurraga, J. P., Reinares, M., Bonnín, C. D. M., Sáez, C., Mur, M., Nieto, E., & Vieta, E. (2015) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2015.04.007 · Cited by 9
Early Detection and Treatment of Psychosis: The Bern Child and Adolescent Psychiatric Perspective
Schultze-Lutter, F., & Schimmelmann, B. (2014) · Advances in Psychiatry · doi:10.1155/2014/365283 · Cited by 9
Griemert, E., Hedrich, J., Hirnet, T., & Thal, S. C. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.6126 · Cited by 9
Modelling first‐year cost‐of‐illness of melanoma attributable to sunbed use in Europe
Krensel, M., Schäfer, I., & Augustin, M. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15313 · Cited by 9
Tissue engineering scaffolds in the treatment of brain disorders in geriatric patients
Niri, A. D., Zarchi, A. A. K., Harati, P. G., Salimi, A., & Mujokoro, B. (2019) · Artificial Organs · doi:10.1111/aor.13485 · Cited by 9
Ramos, S. C., & Ramos, J. A. (2019) · The Family Journal · doi:10.1177/1066480719868706 · Cited by 10
Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in Italy
Mennini, F. S., Marcellusi, A., Gazzillo, S., Nardone, C., Sciattella, P., Migliorini, R., Aurilio, M. T., Amore, M., & Brugnoli, R. (2021) · Clinical Drug Investigation · doi:10.1007/s40261-020-00991-7 · Cited by 9
Tan, L. P., Wang, N., Gu, Z., Zhu, J., Liu, C., & Xu, Z. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6611461 · Cited by 10
Sappok, T., & Steinhart, I. (2021) · Psychiatrische Praxis · doi:10.1055/a-1400-1746 · Cited by 9
Approximation to general economic costs of mental illness
Frank, B. (2022) · European Journal of Economics · doi:10.33422/eje.v2i1.157 · Cited by 9
Peña-Longobardo, L. M., Aranda-Reneo, I., Moreno, J. O., & Castelló, J. V. (2015) · Revista Española de Salud Pública · doi:10.4321/s1135-57272015000100005 · Cited by 9
Braine, M. E., & Cook, N. F. (2015) · Nurse Education Today · doi:10.1016/j.nedt.2015.05.021 · Cited by 9
Misiak, B., & Kiejna, A. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.03.033 · Cited by 9
Geraedts, A. S., Fokkema, M., Kleiboer, A. M., Smit, F., Wiezer, N. W., Majo, M. C., van Mechelen, W., Cuijpers, P. J., & Penninx, B. W. J. H. (2014) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000000234 · Cited by 10
Lainé, A., Anttila, M., & Välimäki, M. (2015) · Informatics for Health and Social Care · doi:10.3109/17538157.2015.1008487 · Cited by 10
Psychotherapy and Mental Health as a Psychological Science Discipline
Wïttchen, H., Härtling, S., & Hoyer, J. (2015) · Verhaltenstherapie · doi:10.1159/000430772 · Cited by 9
Understanding in vivo modelling of depression in non‐human animals: a systematic review protocol
Bannach‐Brown, A., Liao, J., Wegener, G., & Macleod, M. R. (2016) · Evidence-based Preclinical Medicine · doi:10.1002/ebm2.24 · Cited by 9
Expenditures on Mental Health Care in the Czech Republic in 2015
Broulíková, H. M., Dlouhý, M., & Winkler, P. (2019) · Psychiatric Quarterly · doi:10.1007/s11126-019-09688-3 · Cited by 9
OECD (2018) · Health at a glance. Europe · doi:10.1787/health_glance_eur-2018-26-en · Cited by 9
Sleep and Circadian Rhythm Disruption in Psychosis
Peirson, S. N., & Foster, F. (2015) · Wiley eBooks · doi:10.1002/9781118467831.ch18 · Cited by 9
Novel Concepts in Epileptogenesis and its Prevention
Jehi, L. E., & Vezzani, A. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0268-z · Cited by 9
The Impact of Depression on Employment of Older Workers in Europe
Knebelmann, J., & Prinz, C. (2016) · OECD social employment and migration working papers · doi:10.1787/106dbdae-en · Cited by 9
Epidemiology of Psychotic Disorders
Perälä, J. (2013) · Työväentutkimus Vuosikirja · Cited by 9
Yuan, M., Xiao, Z., Zhou, H.-Y., Fu, A., & Pei, Z. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1234252 · Cited by 11
Burden of disease in adolescents and young people in Spain
Catalá-López, F., Gènova-Maleras, R., Álvarez-Martín, E., de Larrea‐Baz, N. F., & Morant-Ginestar, C. (2012) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2012.07.002 · Cited by 8
A web-based adolescent depression support system: feedback and implications for the future
Anttila, K., Anttila, M., & Valimaki, M. A. (2019) · Informatics for Health and Social Care · doi:10.1080/17538157.2019.1656206 · Cited by 10
Pérez‐Bárcena, J., Castaño-León, A. M., Lagares, A., Barea‐Mendoza, J. A., Navarro-Main, B., Pons, J. P., Párraga, L. D. M. P., Ibáñez, J., Chico‐Fernández, M., Llompart‐Pou, J. A., et al. (2021) · Medicine · doi:10.1097/md.0000000000024206 · Cited by 8
Dams, J., Zapp, J.-J., & König, H. (2023) · PharmacoEconomics · doi:10.1007/s40273-023-01289-0 · Cited by 8
Majuri, M., & Wallius, M.-A. (2023) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2023.102534 · Cited by 8
Bohmeier, B., Cybinski, L. M., Gromer, D., Bellinger, D., Deckert, J., Erhardt, A., Deserno, L., Mühlberger, A., Pauli, P., Polak, T. T., et al. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115232 · Cited by 9
Vos, P. C., Išgum, I., Biesbroek, J. M., Velthuis, B. K., & Viergever, M. A. (2013) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2006222 · Cited by 8
Self-citationEvaluation of an integrated care program for schizophrenia: concept and study design
Kerkemeyer, L., Mostardt, S., Biermann, J., Wasem, J., Neumann, A., Walendzik, A., Jahn, R., Bartels, C., Falkai, P., Brannath, W., et al. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0508-6 · Cited by 8
Jacobi, F., & Groß, J. (2014) · Die Psychiatrie · doi:10.1055/s-0038-1670774 · Cited by 8
Self-citationSchwab, B., Daniel, H. S., Lütkemeyer, C., Neves, J. A. L. L., Zilli, L. N., Guarnieri, R., Díaz, A. P., & Michels, A. M. M. P. (2015) · Trends in Psychiatry and Psychotherapy · doi:10.1590/2237-6089-2015-0013 · Cited by 8
Hypothalamic-pituitary-gonadal axis dysfunction: An innate pathophysiology of schizophrenia?
Du, X., & Hill, R. (2019) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2019.02.009 · Cited by 8
Игнатова, Д., Kamusheva, M., Petrova, G. I., & Onchev, G. (2019) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-019-01700-2 · Cited by 8
Ortiz-Fernández, L., Zabala, J. S., Ruiz, A. G., Imaz-Ayo, N., Alava-Menica, A., & Arana‐Arri, E. (2019) · Methods and Protocols · doi:10.3390/mps2020050 · Cited by 8
Heart Rate Variability as a Translational Biomarker for Emotional and Cognitive Deficits
Ellenbroek, B. A., Kidwell, M., Colussi‐Mas, J., & Youn, J. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00013-8 · Cited by 7
Miljković, S., Smajlović, D., TiricCampara, M., Jurina, R., Vinković, L. D., Jankovic, S., Begović, B., & Ćeranić, M. (2018) · Europe PMC (PubMed Central) · Cited by 8
‘Precision’ or ‘personalized’ psychiatry: different terms – same content?
Perna, G., Cuniberti, F., Daccò, S., Grassi, M., & Caldirola, D. (2020) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-1211-2722 · Cited by 9
Geyti, C., Christensen, K. S., Dalsgaard, E., Bech, B. H., Gunn, J. M., Maindal, H. T., & Sandbæk, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-037731 · Cited by 9
Implantable and Wearable Neuroengineering Education: A Review of Postgraduate Programmes
Ghannam, R., Curia, G., Brante, G. G. D. O., Khosravi, S., & Fan, H. (2020) · IEEE Access · doi:10.1109/access.2020.3040064 · Cited by 8
Gargot, T., Kisand, H., Miguel, A., Kayahan, S. T., Soron, T. R., Serene, B., Feron, G., Žaja, N., Valdés-Florido, M. J., Soto-Angona, Ó., et al. (2020) · European Journal of Trauma & Dissociation · doi:10.1016/j.ejtd.2020.100193 · Cited by 7
Holmen, H., Riiser, K., Løyland, B., Sandbekken, I. H., Almendingen, K., Andenæs, R., Bjørnnes, A. K., Fagerlund, B. H., Früh, E. A., Helseth, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043697 · Cited by 8
Županič, E., Wimo, A. B., Winblad, B. G., & Kramberger, M. G. (2022) · Slovenian Journal of Public Health · doi:10.2478/sjph-2022-0011 · Cited by 8
European Academy of Neurology 2019 ‐ 2022
Bassetti, C. L. (2022) · European Journal of Neurology · doi:10.1111/ene.15421 · Cited by 8
Karamustafalıoğlu, O., Reif, A., Atmaca, M., González, D., Moreno-Manzanaro, M., Gonzalez, M. A., Medina, E., & Bellomo, A. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0246-3 · Cited by 8
Vos, P. C., Biesbroek, J. M., Weaver, N. A., Velthuis, B. K., & Viergever, M. A. (2013) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2008074 · Cited by 8
Self-citationEpigenetics in adaptive evolution and development
House, S. H. (2013) · Nutrition and Health · doi:10.1177/0260106014537160 · Cited by 8
Interventional Ischemic Stroke Treatment – A (R)evolution
Friedrich, B., Gawlitza, M., Fahnert, J., Quäschling, U., Kahn, T., Lobsien, D., & Hoffmann, K. (2015) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/s-0041-106899 · Cited by 8
Chen, W., Wang, S., Wang, Q., & Wang, W. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015652 · Cited by 8
Lloret‐Linares, C., Daali, Y., Chevret, S., Nieto, I., Molière, F., Courtet, P., Galtier, F., Richieri, R. M., Morange, S., Llorca, P., et al. (2017) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-017-0173-2 · Cited by 8
Antunes, A., Frasquilho, D., Lopes, S. A., Silva, M., Cardoso, G., & Caldas‐de‐Almeida, J. M. (2018) · International Journal for Equity in Health · doi:10.1186/s12939-018-0821-1 · Cited by 8
Prevention of Internalized Problems of Children and Youth in Academic Setting
Novak, M., & Mihić, J. (2018) · InTech eBooks · doi:10.5772/intechopen.75590 · Cited by 10
Economic Evaluation of Mobile Mental Health Units in Greece: The Case of Cyclades Islands
Lykomitrou, A., Geitona, M., Stylianidis, S., Pantelidou, S., & Souliotis, K. N. (2020) · Health · doi:10.4236/health.2020.127066 · Cited by 8
Parkinson’s Disease in Romania: A Scoping Review
Roşca, E. C., Tudor, R., Cornea, A., & Simu, M. A. (2021) · Brain Sciences · doi:10.3390/brainsci11060709 · Cited by 9
Epidemiologische Beiträge zur Klinischen Psychologie
Wïttchen, H., & Jacobi, F. (2011) · Springer-Lehrbuch · doi:10.1007/978-3-642-13018-2_3 · Cited by 9
Self-citationfor the PREMA-study group, Lukaschek, K., Mergenthal, K., Heider, D., Hanke, A., Munski, K., Moschner, A., Emig, M., van den Akker, M., Zapf, A., et al. (2019) · Trials · doi:10.1186/s13063-019-3751-3 · Cited by 8
Stapel, B., Alvarenga, M. E., & Kahl, K. G. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1490585 · Cited by 8
Liu, Y., Tong, J., Chen, L., Chen, W. J., & Yang, Y. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.04.032 · Cited by 7
de Goumoëns, V., Ayigah, K., Joye, D., Ryvlin, P., & Ramelet, A. (2021) · Journal of Family Nursing · doi:10.1177/10748407211048217 · Cited by 7
Jöhr, J., Martinez, T., Marquis, R., Bruce, S., Binz, P., Rey, S., Hafner, G., Attwell, C., & Diserens, K. (2023) · Cureus · doi:10.7759/cureus.44878 · Cited by 7
The Effect of Transcranial Direct Current Stimulation (tDCS) on Anorexia Nervosa: A Narrative Review
Chmiel, J., Gładka, A., & Leszek, J. (2023) · Nutrients · doi:10.3390/nu15204455 · Cited by 12
Pediatria do Neurodesenvolvimento. Levantamento nacional de recursos e necessidades
Oliveira, G., Duque, F., Duarte, C., Melo, F., Teles, L., Brito, M., Vale, M. C., Guimarães, M. J., & de Gouveia, R. H. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.25754/pjp.2012.630 · Cited by 7
Bandelow, B., Lueken, U., Wolff, J., Godemann, F., Wolff‐Menzler, C., Deckert, J., Ströhle, A., Beutel, M., Wiltink, J., Domschke, K., et al. (2016) · Der Nervenarzt · doi:10.1007/s00115-016-0085-1 · Cited by 7
Neurology's Silent Killer: Drug-Resistant Epilepsy
Jehi, L. E. (2016) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7511-16.4.232 · Cited by 7
Falkenberg, I., Valli, I., Raffin, M., Broome, M. R., Fusar‐Poli, P., Matthíasson, P., Picchioni, M., & McGuire, P. K. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.09.023 · Cited by 7
Optimizing the deep brain stimulation care pathway in patients with Parkinson’s disease
Thomas, N. J., Mertens, P., Danaila, T., Polo, G., Klinger, H., Broussolle, E., & Thobois, S. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8548-2 · Cited by 7
Jůza, R., Štefková, K., Dehaen, W., Randáková, A., Petrásek, T., Vojtěchová, I., Kobrlová, T., Pulkrabkova, L., Múčková, Ľ., Mecava, M., et al. (2021) · Biomolecules · doi:10.3390/biom11091262 · Cited by 7
França, M. H., Pereira, F. G., Wang, Y., Andrade, L. H., Alonso, J., & Viana, M. C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.070 · Cited by 11
Self-citationRinaldi, G., Osman, N., Kaess, M., SCHIMMELMANN, B. G., Kindler, J., Schultze‐Lutter, F., & Michel, C. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2457 · Cited by 7
Pharmacological Treatments of Sleep–Wake Disorders: Update 2023
Kallweit, M. S., Kallweit, N. P., & Kallweit, U. (2023) · Clinical and Translational Neuroscience · doi:10.3390/ctn7040042 · Cited by 8
Serum amyloid P component accumulates and persists in neurones following traumatic brain injury
Yip, P. K., Liu, Z., Hasan, S., Pepys, M. B., & Uff, C. E. G. (2023) · Open Biology · doi:10.1098/rsob.230253 · Cited by 6
Slot, M. I. E., van Hell, H. H., Rossum, I. W.-V., Dazzan, P., Maat, A., de Haan, L., Crespo‐Facorro, B., Glenthoj, B. Y., Lawrie, S. M., McDonald, C., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.02.018 · Cited by 8
Jennum, P., Ibsen, R., & Kjellberg, J. (2014) · European Neurology · doi:10.1159/000367653 · Cited by 7
Self-citationMeuldijk, D., Carlier, I. V. E., van Vliet, I. M., Marle, M. E. V. D. A., & Zitman, F. G. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2012.05.002 · Cited by 7
Metadata
- Authors
- Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Ekman, M., Faravelli, C., Fratiglioni, L., Gannon, B., Jones, D. H., Jennum, P., Jordanova, A., Jönsson, L., Karampampa, K., Knapp, M., Kobelt, G., Kurth, T., Lieb, R., Linde, M., Ljungcrantz, C., Maercker, A., Melin, B., Moscarelli, M., Musayev, A., Norwood, F., Preisig, M., Pugliatti, M., Rehm, J., Salvador-Carulla, L., Schlehofer, B., Simon, R., Steinhausen, H.-C., Stovner, L. J., Vallat, J.-M., den Bergh, P. V., van Os, J., Vos, P., Xu, W., Wittchen, H.-U., Jönsson, B., & Olesen, J.
- Affiliations
- Karlstad University (SE)
- Technische Universität Dresden (DE)
- Karolinska University Hospital (SE)
- Municipal Institute for Medical Research (ES)
- Mario Negri Institute for Pharmacological Research (IT)
- Philipps University of Marburg (DE)
- University of Florence (IT)
- Karolinska Institutet (SE)
- University of Leeds (GB)
- Glostrup Hospital (DK)
- University of Antwerp (BE)
- King's College London (GB)
- Lund University (SE)
- Harvard University (US)
- University of Basel (CH)
- Norwegian University of Science and Technology (NO)
- Umeå University (SE)
- King's College Hospital (GB)
- Centre Hospitalier Universitaire Vaudois (CH)
- University of Sassari (IT)
- German Cancer Research Center (DE)
- European Monitoring Centre for Drugs and Drug Addiction (PT)
- Aalborg University Hospital (DK)
- Centre Hospitalier Universitaire de Limoges (FR)
- Radboud University Nijmegen (NL)
- Stockholm School of Economics (SE)
- Corresponding author
- Olesen, Jes
- ORCID
- Gustavsson, Anders
- Svensson, Mikael
- Jacobi, Frank
- Alonso, Jordi
- Beghi, Ettore
- Dodel, Richard
- Ekman, Mattias
- Fratiglioni, Laura
- Gannon, Brenda
- Jennum, Poul
- Jordanova, Albena
- Jönsson, Linus
- Karampampa, Korinna
- Knapp, Martin
- Kobelt, Gisela
- Kurth, Tobias
- Lieb, Roselind
- Linde, Mattias
- Ljungcrantz, Christina
- Melin, Beatrice
- Moscarelli, Massimo
- Preisig, Martin
- Pugliatti, Maura
- Steinhausen, Hans-Christoph
- Stovner, Lars Jacob
- Vallat, Jean-Michel
- Xu, Weili
- Olesen, Jes
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2011-10
- Volume
- 21
- Issue
- 10
- Pages
- 718-779
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2131786905
- Cited by
- 1,723
- References
- 427
- Citations by year
- 2026: 42 · 2025: 64 · 2024: 70 · 2023: 88 · 2022: 100 · 2021: 133 · 2020: 123 · 2019: 120 · 2018: 233 · 2017: 130 · 2016: 141 · 2015: 142 · 2014: 124 · 2013: 118 · 2012: 81
- FWCI
- 145.35
- Type
- journal article
- Language
- en
- Open access
- green
- tud.qucosa.de
- Licence
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- Florence Research (University of Florence) (submittedVersion)
- IRIS (submittedVersion)
- UnissResearch (Università degli Studi di Sassari) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Qucosa (Saxon State and University Library Dresden) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- mental illness, neurological disorders, economic burden, prevalence, direct and indirect costs, cost model, Europe, brain tumors, dementia, epilepsy, multiple sclerosis, stroke, traumatic brain injury, Parkinson's disease, migraine, developmental disorders, neuromuscular disorders, sleep disorders, somatoform disorders, cost per person
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Mental Disorders, Brain Diseases, Child, Child, Preschool, Europe, Health Expenditures, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Public Health, Prevalence, Health Care Costs, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
